Digital Biomarkers Market Size worth close to USD 36 million by 2035 | Roots Analysis
According to Roots Analysis, the Digital Biomarkers Market is anticipated to be worth USD 5.6 billion in 2024, and this value is likely to reach over USD 35.8 billion by 2035, expanding at a CAGR of 18.5%.
Digital biomarkers are measurable indicators that are collated using digital health tools, including wearable devices, smartphones and software; these indicators provide objective information regarding a persons health (by analysing heart rate, blood pressure, sleep cycle and activity pattern).
It is worth highlighting that digital biomarkers play a significant role in advancing precision medicine, enabling timely and targeted interventions based on the persons health information.
Key Report Takeaways
The digital biomarkers domain is primarily led by emerging firms and start-ups; over 50% of the digital biomarker developers are based in North America (specifically the US)
In achieve a competitive edge over other stakeholders, players are actively undertaking initiatives to incorporate advanced features in their respective digital biomarkers
Around 40% of the partnerships in this domain were inked in the last two years; further, product / technology integration agreements emerged as the most prominent partnership model adopted by stakeholders
Foreseeing a lucrative potential within this domain, several companies have invested significant amount across more than 160 funding instances, since 2015; majority of the funds were raised for developing imaging biomarkers
Around 75% of the patents related to digital biomarkers were patent applications while around 30% were granted patents
Considering the growing demand for real-time tracking health tools and shift towards personalized therapeutics, digital biomarkers market is anticipated to grow at a significant rate, till 2035
Competitive Landscape:
The digital biomarkers market features more than 220 digital biomarkers. Over 40% of the data collection / analysis tools are software platforms while 40% are mobile applications.
Further, more than 40% of the digital solutions collect / analyze data related to various physiological biomarkers. In terms of digital biomarker developers, the overall landscape seems to be well-fragmented, comprising of large, mid-sized, small and very small players. Nearly 90% of the North America based digital biomarker developers are based in the US while 20% of the firms based in Europe are located in the UK.
Regional Outlook
Based on the key geographical regions, the digital biomarkers market can be segmented into five major regions, including North America, Europe, Asia Pacific, Middle East and North Africa, and Rest of the World. North America is anticipated to capture the majority share of the market in 2024 and this trend is likely to remain unchanged during the forecast period.
Further, Asia Pacific is accounted to be the fastest-growing segment of the market. The growth of the digital biomarker market in the region is driven by the rising number of decentralized trials and increasing prevalence of chronic diseases in this region.
Key Players
Examples of key companies engaged in digital biomarkers market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Acculi Labs, ActiGraph, AliveCor, ATCOR, BACtrack, Biogen, BioSerenity, BioSensics, Eyenuk, Empatica, Feel Therapeutics, icometrix, iMediSync, IXICO, Kinsa, Koneksa Health, Kontigo Care, Progentec Diagnostics, Quibim, Vocalis Health.
It is interesting to note that in October 2023, Oura signed a product / technology integration agreement with FitOn to collaboratively offer an exclusive experience of tracking activity, readiness and sleep.
Market Segments
Based on the research, Roots Analysis has segmented the digital biomarkers market into type of product, purpose of solution, type of biomarker, therapeutic area and key geographical regions.
by Type of Product
Software / Applications
Wearables
Sensors
Gaming Solutions
by Purpose of Solution
Diagnosis Digital Biomarkers
Early Screening Digital Biomarkers
Monitoring Digital Biomarkers
Predictive Insights Digital Biomarkers
by Type of Biomarker
Cognitive
Idiosyncratic
Physiological
Vocal
Others
by Therapeutic Area
Autoimmune Disorders
Cardiovascular Disorders
Infectious Diseases
Mental Health Disorders
Neurological Disorders
Respiratory Disorders
Substance Abuse Disorders
Other Disorders
by Type of Business Model
B2B
B2C
by Key Geographical Regions
North America
Europe
Asia Pacific
Middle East and North Africa
Rest of the World
About Roots Analysis
Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
Contact US
Gaurav Chaudhary
Email: sales@rootsanalysis.com
